Previous research showed that the risk of HUA was increased in patients with SCH (2), and L-T4 replacement therapy could decrease serum UA levels in patients with recent onset SCH, indicating the influential role of thyroid hormones for modulating UA metabolism (9). Here, TG is linked to spindle cell hemangioma.